Found: 518
Select item for more details and to access through your institution.
Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial
- Published in:
- 2019
- By:
- Publication type:
- journal article
Burst steroid therapy for acute heart failure: The CORTAHF randomized, open‐label, pilot trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 10, p. 2282, doi. 10.1002/ejhf.3452
- By:
- Publication type:
- Article
The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 10, p. 2077, doi. 10.1002/ejhf.3412
- By:
- Publication type:
- Article
Sealing of coronary artery aneurysm by using a new stent graft.
- Published in:
- Catheterization & Cardiovascular Interventions, 1999, v. 48, n. 1, p. 96, doi. 10.1002/(SICI)1522-726X(199909)48:1<96::AID-CCD20>3.0.CO;2-2
- By:
- Publication type:
- Article
Intracoronary stent placement proximal to a myocardial bridge: Immediate and long-term results.
- Published in:
- Catheterization & Cardiovascular Interventions, 1999, v. 46, n. 3, p. 363, doi. 10.1002/(SICI)1522-726X(199903)46:3<363::AID-CCD24>3.0.CO;2-V
- By:
- Publication type:
- Article
European cardiac resynchronization therapy survey II: rationale and design.
- Published in:
- 2015
- By:
- Publication type:
- journal article
European Cardiac Resynchronization Therapy Survey II: rationale and design.
- Published in:
- EP: Europace, 2015, v. 17, n. 1, p. 137, doi. 10.1093/europace/euu312
- By:
- Publication type:
- Article
European Cardiac Resynchronization Therapy Survey II: rationale and design.
- Published in:
- EP: Europace, 2015, v. 17, n. 1, p. 137, doi. 10.1093/europace/euu312
- By:
- Publication type:
- Article
Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone—Translational Aspects and Clinical Perspectives across Multiple Organ Systems.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 16, p. 9243, doi. 10.3390/ijms23169243
- By:
- Publication type:
- Article
Short-term Mortality Risk in Emergency Department Acute Heart Failure.
- Published in:
- Academic Emergency Medicine, 2011, v. 18, n. 9, p. 947, doi. 10.1111/j.1553-2712.2011.01150.x
- By:
- Publication type:
- Article
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 7, p. 1261, doi. 10.1093/ndt/gfab336
- By:
- Publication type:
- Article
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 6, p. 1014, doi. 10.1093/ndt/gfaa294
- By:
- Publication type:
- Article
Potential Utility of Neurosonology in Paroxysmal Atrial Fibrillation Detection in Patients with Cryptogenic Stroke.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 11, p. 2002, doi. 10.3390/jcm8112002
- By:
- Publication type:
- Article
Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial.
- Published in:
- Stem Cells Translational Medicine, 2024, v. 13, n. 2, p. 116, doi. 10.1093/stcltm/szad078
- By:
- Publication type:
- Article
Ghidul Societăţii Europene de Cardiologie (ESC) 2020 pentru diagnosticul şi tratamentul fibrilaţiei atriale elaborat în colaborare cu Asociaţia Europeană de Chirurgie Cardio-Toracică (EACTS).
- Published in:
- Romanian Journal of Cardiology, 2021, v. 31, n. 3, p. 641
- By:
- Publication type:
- Article
Characteristics of patients with heart failure from Romania enrolled in - ESC-HF Long-Term (ESC-HF-LT) Registry.
- Published in:
- Romanian Journal of Cardiology, 2015, v. 25, n. 4, p. 413
- By:
- Publication type:
- Article
Ghidul ESC de diagnostic şi tratament al insuficienţei cardiace acute şi cronice 2012.
- Published in:
- Romanian Journal of Cardiology, 2013, v. 23, n. 3, p. 245
- By:
- Publication type:
- Article
Wytyczne ESC/EACTS dotyczące rewaskularyzacji mięśnia sercowego w 2014 roku.
- Published in:
- Polish Heart Journal / Kardiologia Polska, 2014, v. 72, n. 12, p. 1253, doi. 10.5603/KP.2014.0224
- By:
- Publication type:
- Article
Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01943-z
- By:
- Publication type:
- Article
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists.
- Published in:
- Diabetologia, 2024, v. 67, n. 2, p. 246, doi. 10.1007/s00125-023-06031-1
- By:
- Publication type:
- Article
Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials.
- Published in:
- European Stroke Journal, 2023, v. 8, n. 1, p. 106, doi. 10.1177/23969873221139410
- By:
- Publication type:
- Article
Pacemaker Endocarditis With Sizeable Vegetation and Intermittent Fever.
- Published in:
- Echocardiography, 2003, v. 20, n. 3, p. 295, doi. 10.1046/j.1540-8175.2003.03031.x
- By:
- Publication type:
- Article
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2578, doi. 10.1111/dom.15572
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. C1, doi. 10.1111/dom.15423
- By:
- Publication type:
- Article
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 191, doi. 10.1111/dom.15305
- By:
- Publication type:
- Article
Back Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. C4, doi. 10.1111/dom.15286
- By:
- Publication type:
- Article
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2989, doi. 10.1111/dom.15197
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1, doi. 10.1111/dom.15115
- By:
- Publication type:
- Article
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1512, doi. 10.1111/dom.14999
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
- By:
- Publication type:
- Article
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon‐like peptide‐1 receptor agonist use.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 407, doi. 10.1111/dom.14883
- By:
- Publication type:
- Article
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 125, doi. 10.1111/dom.14558
- By:
- Publication type:
- Article
Identification of Chronic Heart Failure Patients with a High 12-Month Mortality Risk Using Biomarkers Including Plasma C-Terminal Pro-Endothelin-1.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0014506
- By:
- Publication type:
- Article
Management of cardiac sarcoidosis: A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC
- Published in:
- European Heart Journal, 2024, v. 45, n. 30, p. 2697, doi. 10.1093/eurheartj/ehae356
- By:
- Publication type:
- Article
Cancer begets atrial fibrillation ... and vice versa?
- Published in:
- European Heart Journal, 2024, v. 45, n. 25, p. 2214, doi. 10.1093/eurheartj/ehae301
- By:
- Publication type:
- Article
Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 37, p. 3672, doi. 10.1093/eurheartj/ehad557
- By:
- Publication type:
- Article
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2947, doi. 10.1093/eurheartj/ehad335
- By:
- Publication type:
- Article
Pre-treatment bicarbonate levels and decongestion by acetazolamide: the ADVOR trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 22, p. 1995, doi. 10.1093/eurheartj/ehad236
- By:
- Publication type:
- Article
Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry.
- Published in:
- European Heart Journal, 2023, v. 44, n. 17, p. 1526, doi. 10.1093/eurheartj/ehad109
- By:
- Publication type:
- Article
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 5, p. 396, doi. 10.1093/eurheartj/ehac693
- By:
- Publication type:
- Article
Albuminuria as a marker of systemic congestion in patients with heart failure.
- Published in:
- European Heart Journal, 2023, v. 44, n. 5, p. 368, doi. 10.1093/eurheartj/ehac528
- By:
- Publication type:
- Article
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme.
- Published in:
- European Heart Journal, 2022, v. 43, n. 48, p. 4991, doi. 10.1093/eurheartj/ehac495
- By:
- Publication type:
- Article
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 41, p. 4362, doi. 10.1093/eurheartj/ehac401
- By:
- Publication type:
- Article
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 36, p. 3435, doi. 10.1093/eurheartj/ehac320
- By:
- Publication type:
- Article
Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction.
- Published in:
- European Heart Journal, 2022, v. 43, n. 23, p. 2224, doi. 10.1093/eurheartj/ehac103
- By:
- Publication type:
- Article
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 23, p. 2212, doi. 10.1093/eurheartj/ehac144
- By:
- Publication type:
- Article
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.
- Published in:
- European Heart Journal, 2022, v. 43, n. 6, p. 474, doi. 10.1093/eurheartj/ehab777
- By:
- Publication type:
- Article
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.
- Published in:
- European Heart Journal, 2022, v. 43, n. 5, p. 416, doi. 10.1093/eurheartj/ehab798
- By:
- Publication type:
- Article
Sodium glucose co-transporter inhibitors and heart failure outcomes across different patient populations.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4887, doi. 10.1093/eurheartj/ehab704
- By:
- Publication type:
- Article
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 43, p. 4455, doi. 10.1093/eurheartj/ehab579
- By:
- Publication type:
- Article